靶点- |
作用机制- |
|
|
|
非在研适应症- |
最高研发阶段临床前 |
首次获批国家/地区- |
首次获批日期- |
靶点- |
作用机制- |
在研机构- |
|
在研适应症- |
|
最高研发阶段无进展 |
首次获批国家/地区- |
首次获批日期- |
Dose Escalation Safety Study of MM-10-001
The purpose of this study is to evaluate the safety of increasing doses of MM-10-001 and to determine the dose of MM-10-001 that enhances the immune system in normal healthy subjects.
100 项与 GlycaNova Norge AS 相关的临床结果
0 项与 GlycaNova Norge AS 相关的专利(医药)
100 项与 GlycaNova Norge AS 相关的药物交易
100 项与 GlycaNova Norge AS 相关的转化医学